Gradual Expansion of a Stent to Prevent Periprocedural Complications After Carotid Artery Stenting for Vulnerable Severe Stenotic Lesions with Intraplaque Hemorrhages: A Retrospective Observational Study

Overview

Journal Life (Basel)

Specialty Biology

Date 2022 Jan 21

PMID 35054523

Authors

Takahisa Mori

Kazuhiro Yoshioka

Yuhei Tanno

Shigen Kasakura

Affiliations

Soon will be listed here.

Abstract

Vulnerable lesions with intraplaque hemorrhages are associated with a high incidence of complications following carotid artery stenting (CAS). CAS for vulnerable lesions has not been established; therefore, we gradually expand stents in such patients. This study aimed to compare the incidences of complications between gradual-expansion CAS for vulnerable lesions and standard CAS for non-vulnerable lesions. For gradual-expansion CAS, we used 3.0 or 4.0 mm balloons for minimal luminal diameters (MLDs) <2.0 or ≥2.0 mm, respectively, for pre-stenting angioplasty (SA) and did not overinflate them. By contrast, for standard CAS, we used a 4.0 mm balloon and overinflated it to 4.23 mm. A closed-cell stent was deployed, and post-SA was not performed in both groups. We evaluated the MLD before and minimal stent diameter (MSD) immediately after CAS, as well as periprocedural complications of combined stroke, death, and myocardial infarction within 30 days after CAS. In the vulnerable and non-vulnerable groups, 30 and 38 patients were analyzed, the MLDs were 0.76 and 0.96 mm before CAS, the MSDs were 2.97 mm and 3.58 mm after CAS, and the numbers of complications were 0 and 1, respectively. Gradual-expansion CAS for vulnerable lesions was as safe as standard CAS for non-vulnerable lesions.

References

Mori T, Yoshioka K, Tanno Y, Kasakura S, Miyazaki Y . Reduced magnetic resonance angiography signal intensity in the middle cerebral artery ipsilateral to severe carotid stenosis may be a practical index of high oxygen extraction fraction. Eur Radiol. 2021; 32(3):2023-2029. PMC: 8831255. DOI: 10.1007/s00330-021-08272-3. View

Takigawa T, Matsumaru Y, Hayakawa M, Nemoto S, Matsumura A . Cilostazol reduces restenosis after carotid artery stenting. J Vasc Surg. 2009; 51(1):51-6. DOI: 10.1016/j.jvs.2009.08.040. View

Iwata T, Mori T, Miyazaki Y, Nakazaki M, Takahashi Y, Mizokami K . Initial experience of a novel sheath guide for transbrachial carotid artery stenting: technical note. J Neurointerv Surg. 2012; 5 Suppl 1:i77-80. DOI: 10.1136/neurintsurg-2012-010506. View

Martin J, Pache J, Murphy K, Gailloud P, Puget E, Pizzolato G . Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke. 2001; 32(2):479-84. DOI: 10.1161/01.str.32.2.479. View

Bussiere M, Pelz D, Kalapos P, Lee D, Gulka I, Leung A . Results using a self-expanding stent alone in the treatment of severe symptomatic carotid bifurcation stenosis. J Neurosurg. 2008; 109(3):454-60. DOI: 10.3171/JNS/2008/109/9/0454. View

Yoshimura S, Yamada K, Kawasaki M, Asano T, Kanematsu M, Takamatsu M . High-intensity signal on time-of-flight magnetic resonance angiography indicates carotid plaques at high risk for cerebral embolism during stenting. Stroke. 2011; 42(11):3132-7. DOI: 10.1161/STROKEAHA.111.615708. View

Kurosaki Y, Yoshida K, Fukumitsu R, Sadamasa N, Handa A, Chin M . Carotid artery plaque assessment using quantitative expansive remodeling evaluation and MRI plaque signal intensity. J Neurosurg. 2015; 124(3):736-42. DOI: 10.3171/2015.2.JNS142783. View

Mori T, Yoshioka K, Tanno Y, Kasakura S . Intentional Stent Stenosis to Prevent Hyperperfusion Syndrome after Carotid Artery Stenting for Extremely High-Grade Stenosis. AJNR Am J Neuroradiol. 2020; 42(1):132-137. PMC: 7814797. DOI: 10.3174/ajnr.A6853. View

Douglas Jr J, Holmes Jr D, Kereiakes D, Grines C, Block E, Ghazzal Z . Coronary stent restenosis in patients treated with cilostazol. Circulation. 2005; 112(18):2826-32. DOI: 10.1161/CIRCULATIONAHA.104.530097. View

10.

Liem M, Kennedy F, Bonati L, van der Lugt A, Coolen B, Nederveen A . Investigations of Carotid Stenosis to Identify Vulnerable Atherosclerotic Plaque and Determine Individual Stroke Risk. Circ J. 2017; 81(9):1246-1253. DOI: 10.1253/circj.CJ-16-1284. View

11.

Ogata A, Sonobe M, Kato N, Yamazaki T, Kasuya H, Ikeda G . Carotid artery stenting without post-stenting balloon dilatation. J Neurointerv Surg. 2013; 6(7):517-20. PMC: 4145433. DOI: 10.1136/neurintsurg-2013-010873. View

12.

Nakazaki M, Nonaka T, Takahashi A, Yonemasu Y, Nomura T, Onda T . Double balloon protection during carotid artery stenting for vulnerable carotid stenosis reduces the incidence of new brain lesions. Acta Neurochir (Wien). 2016; 158(7):1377-86. DOI: 10.1007/s00701-016-2816-2. View

13.

Saba L, Yuan C, Hatsukami T, Balu N, Qiao Y, DeMarco J . Carotid Artery Wall Imaging: Perspective and Guidelines from the ASNR Vessel Wall Imaging Study Group and Expert Consensus Recommendations of the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2018; 39(2):E9-E31. PMC: 7410574. DOI: 10.3174/ajnr.A5488. View

14.

Mori T, Kazita K, Chokyu K, Mima T, Mori K . Short-term arteriographic and clinical outcome after cerebral angioplasty and stenting for intracranial vertebrobasilar and carotid atherosclerotic occlusive disease. AJNR Am J Neuroradiol. 2000; 21(2):249-54. PMC: 7975354. View

15.

Kimura T, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y . Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996; 334(9):561-6. DOI: 10.1056/NEJM199602293340903. View

16.

Kuroda H, Ogasawara K, Hirooka R, Kobayashi M, Fujiwara S, Chida K . Prediction of cerebral hyperperfusion after carotid endarterectomy using middle cerebral artery signal intensity in preoperative single-slab 3-dimensional time-of-flight magnetic resonance angiography. Neurosurgery. 2009; 64(6):1065-71. DOI: 10.1227/01.NEU.0000345941.99443.99. View

17.

Barnett H, Taylor D, Eliasziw M, Fox A, Ferguson G, Haynes R . Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998; 339(20):1415-25. DOI: 10.1056/NEJM199811123392002. View

18.

Altaf N, Daniels L, Morgan P, Auer D, MacSweeney S, Moody A . Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J Vasc Surg. 2008; 47(2):337-42. DOI: 10.1016/j.jvs.2007.09.064. View

19.

Yadav J, Wholey M, Kuntz R, Fayad P, Katzen B, Mishkel G . Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004; 351(15):1493-501. DOI: 10.1056/NEJMoa040127. View

20.

Voute M, Hendriks J, van Laanen J, Pattynama P, Muhs B, Poldermans D . Radial force measurements in carotid stents: influence of stent design and length of the lesion. J Vasc Interv Radiol. 2011; 22(5):661-6. DOI: 10.1016/j.jvir.2011.01.450. View